(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 10. CD81 and cholesterol are required for P. falciparum sporozoite invasion of human hepatocytes. (A) Primary human hepatocytes transfected with a siRNA oligonucleotide targeting CD81 (siCD81) or with a control siRNA (cont) were stained with anti-CD81 (mAb TS81, left panel) or anti-CD9 (mAb TS9, right panel) and analyzed by flow cytometry. (B) Quantification of P. falciparum exo-erythrocytic forms (EEFs; mean of triplicate wells ± s.d.) in human hepatocytes transfected with siRNA oligonucleotides targeting CD81 (siCD81) or CD9 (siCD9), or with a control siRNA (control). *P<0.05 as compared to control. (C) Primary human hepatocytes were treated with MßCD followed by MßCD/cholesterol, when indicated, before infection by P. falciparum sporozoites. The number of EEF-infected cells was determined as described in the Materials and Methods section. **P<0.01, as compared to untreated control.